A Phase I-II Study of HM781-36B Combined With Paclitaxel and Trastuzumab in HER-2 Positive Advanced Gastric Cancer

NCT01746771 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

44

Enrollment

INDUSTRY

Sponsor class

Conditions

HER-2 Positive Advanced Gastric Cancer

Interventions

DRUG: HM781-36B(Poziotinib)
DRUG: Paclitaxel
DRUG: Trastuzumab

Sponsor

Hanmi Pharmaceutical Company Limited

Collaborators

[object Object]